Related Experiment Videos
Quinacrine and copper, compounds with anticonceptive and antineoplastic activity
A Dabancens1, J Zipper, A Guerrero
1Department of Experimental Medicine, Faculty of Medicine, Universidad de Chile, Santiago.
Contraception
|September 1, 1994
Summary
Quinacrine and copper synergistically reduced tumor size and promoted regression in mice. This suggests a potential therapeutic approach for certain cancers, especially considering copper
Area of Science:
- Oncology
- Pharmacology
- Toxicology
Background:
- Malignant transplantable tumors in mice were studied.
- Previous research on quinacrine, copper, and zinc in cancer treatment is limited.
Purpose of the Study:
- To investigate the antineoplastic effects of quinacrine, copper, and zinc on tumor evolution in mice.
- To determine if copper and zinc enhance quinacrine's anti-tumor activity.
Main Methods:
- Male AJ mice were inoculated with TA3 or TA3 MTXR tumor cells.
- Mice received quinacrine, copper, and zinc in their drinking water across three experimental designs.
- Tumor size and regression rates were monitored.
Main Results:
- Quinacrine administration, alone or with copper, significantly reduced tumor size.
- Groups receiving quinacrine and copper showed a high rate of complete tumor regression (up to 60%).
- Zinc did not improve quinacrine's anti-tumoral effect, but copper showed synergistic activity.
Conclusions:
- Quinacrine and copper exhibit synergistic anti-cancer activity.
- The findings suggest a potential therapeutic application for quinacrine and copper in cancer treatment.
- This research is relevant for women using copper intrauterine devices (IUDs).